Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases

Invitae  (NYSE: NVTA), a leading medical genetics company, and Deerfield Management Company today announced a partnership to advance genetics-based drug discovery and development in rare disease.